Masaru Mimura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Masaru Mimura has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Ayako Maeda-Minami
Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan
2 shared publications - Eiichi Tahara
Department of Japanese Oriental (Kampo) Medicine, Oriental Medical Center, Iizuka Hospital, 3-83 Yoshio-cho, Iizuka, Fukuoka 920-8505, Japan
2 shared publications - Hideki Mima
Center for Research and Development of Higher Education, University of Tokyo, 7-3-1 Hongou, Bunkyo-ku, Tokyo 113-0033, Japan
2 shared publications - Hiroaki Hikiami
Shikino Care Center, 480 Washikitashin, Takaoka, Toyama 933-0071, Japan
2 shared publications - Kenji Watanabe
Center for Kampo Medicine, Keio University School of Medicine, Tokyo, Japan
2 shared publications - Kiyoshi Minamizawa
Department of Oriental Medicine, Kameda Medical Center, 929 Higashi-cho, Kamogawa, Chiba 296-8602, Japan
2 shared publications
Latest Publications
- 1 March 2020
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 49, 102353
Discrimination of prediction models between cold-heat and deficiency-excess patterns
- 1 March 2020
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 49, 102353
Discrimination of prediction models between cold-heat and deficiency-excess patterns
- 27 November 2019
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 74 (2) , 132-139
Effectiveness of mindfulness‐based cognitive therapy in patients with anxiety disorders in secondary‐care settings: A randomized controlled trial
Aim: The primary objective of this study was to examine the effectiveness of mindfulness‐based cognitive therapy (MBCT) in secondary‐care settings where the vast majority of the patients have already undergone pharmacotherapy but have not remitted.Methods: Eligible participants were aged between 20 and 75 years and met the criteria for panic disorder/agoraphobia or social anxiety disorder specified in the DSM‐IV. They were randomly assigned to either the MBCT group (n = 20) or the wait‐list control group (n = 20). The primary outcome was the difference in mean change scores between pre‐ and post‐intervention assessments on the State–Trait Anxiety Inventory (STAI). The outcome was analyzed using an intent‐to‐treat approach and a mixed‐effect model repeated measurement.Results: We observed significant differences in mean change scores for the STAI State Anxiety subscale (difference, −10.1; 95% confidence interval, −16.9 to −3.2; P < 0.005) and STAI Trait Anxiety subscale (difference, −11.7; 95% confidence interval, −17.0 to −6.4; P < 0.001) between the MBCT and control groups.Conclusion: MBCT is effective in patients with anxiety disorders in secondary‐care settings where the vast majority of patients are treatment‐resistant to pharmacotherapy.
- 27 November 2019
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 74 (2) , 132-139
Effectiveness of mindfulness‐based cognitive therapy in patients with anxiety disorders in secondary‐care settings: A randomized controlled trial
Aim: The primary objective of this study was to examine the effectiveness of mindfulness‐based cognitive therapy (MBCT) in secondary‐care settings where the vast majority of the patients have already undergone pharmacotherapy but have not remitted.Methods: Eligible participants were aged between 20 and 75 years and met the criteria for panic disorder/agoraphobia or social anxiety disorder specified in the DSM‐IV. They were randomly assigned to either the MBCT group (n = 20) or the wait‐list control group (n = 20). The primary outcome was the difference in mean change scores between pre‐ and post‐intervention assessments on the State–Trait Anxiety Inventory (STAI). The outcome was analyzed using an intent‐to‐treat approach and a mixed‐effect model repeated measurement.Results: We observed significant differences in mean change scores for the STAI State Anxiety subscale (difference, −10.1; 95% confidence interval, −16.9 to −3.2; P < 0.005) and STAI Trait Anxiety subscale (difference, −11.7; 95% confidence interval, −17.0 to −6.4; P < 0.001) between the MBCT and control groups.Conclusion: MBCT is effective in patients with anxiety disorders in secondary‐care settings where the vast majority of patients are treatment‐resistant to pharmacotherapy.
- 1 October 2019
- Published by Elsevier in Neurochemistry International
- Vol. 129, 104470
App mice overall do not show impaired motivation, but cored amyloid plaques in the striatum are inversely correlated with motivation
- 1 October 2019
- Published by Elsevier in Neurochemistry International
- Vol. 129, 104470
App mice overall do not show impaired motivation, but cored amyloid plaques in the striatum are inversely correlated with motivation
- 1 August 2019
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 45, 228-233
Prediction of deficiency-excess pattern in Japanese Kampo medicine: Multi-centre data collection
- 1 August 2019
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 45, 228-233
Prediction of deficiency-excess pattern in Japanese Kampo medicine: Multi-centre data collection